title: [Clinical indications for therapeutic drug monitoring of antifungal agents. In the way for optimizing the treatment of fungal infection].
abstract: Therapeutic drug monitoring as a tool in the management of infectious diseases has been introduced in therapy with anti-infective agents for years. Nowadays, it has taken importance in the management of fungal diseases due to the appearance of new antifungal drugs such as new-generation azoles. These azoles have pharmacokinetic characteristics that hinder a proper use to ensure efficacy and minimize toxicity. Monitoring of serum concentrations may help in the better use of these anti-infective agents, as well as in a better management of drug interactions, infectious disease and adverse effects. It has resulted in saving costs of treatment and in avoiding inadequate dosages. This review will attempt to clarify the role of the antifungal agents Therapeutic Drug Monitoring, highlighting the role of azole compounds.
authors.affiliation: Alicia Gómez-López, Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Ctra Majadahonda-Pozuelo Km 2. 28220 Majadahonda (Madrid), Spain. aliciagl@isciii.es.
authors.forename: E
authors.initials: E
authors.lastname: Cendejas-Bueno
authors.forename: M
authors.initials: M
authors.lastname: Cuenca-Estrella
authors.forename: A
authors.initials: A
authors.lastname: Gómez-López
mesh_terms: D000935:Antifungal Agents / Q000097:blood / Q000627:therapeutic use*; D016903:Drug Monitoring / Q000592:standards*; D006801:Humans; D009181:Mycoses / Q000188:drug therapy*
chemical_list: D000935:Antifungal Agents